These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 11186016)
1. [Peptide-oligonucleotide conjugates as a new generation of antisense elements]. Stetsenko DA; Arzumanov AA; Korshun VA; Gait MJ Mol Biol (Mosk); 2000; 34(6):998-1006. PubMed ID: 11186016 [No Abstract] [Full Text] [Related]
2. Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates. Diala I; Murao S; Fujii M Nucleic Acids Symp Ser (Oxf); 2008; (52):679-80. PubMed ID: 18776562 [TBL] [Abstract][Full Text] [Related]
3. Controlled intracellular localization and enhanced antisense effect of oligonucleotides by chemical conjugation. Kubo T; Zhelev Z; Bakalova R; Ohba H; Doi K; Fujii M Org Biomol Chem; 2005 Sep; 3(18):3257-9. PubMed ID: 16132084 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of oligonucleotide-peptide conjugates for biomedical and technological applications. Aviñó A; Grijalvo S; Pérez-Rentero S; Garibotti A; Terrazas M; Eritja R Methods Mol Biol; 2011; 751():223-38. PubMed ID: 21674334 [TBL] [Abstract][Full Text] [Related]
5. Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini. Grijalvo S; Terrazas M; Aviñó A; Eritja R Bioorg Med Chem Lett; 2010 Apr; 20(7):2144-7. PubMed ID: 20206515 [TBL] [Abstract][Full Text] [Related]
6. The solution synthesis of antisense oligonucleotide-peptide conjugates directly linked via phosphoramide bond by using a fragment coupling approach. Sumbatyan NV; Mandrugin VA; Deroussent A; Bertrand JR; Majer Z; Malvy C; Korshunova GA; Hollosi M; Gottikh MB Nucleosides Nucleotides Nucleic Acids; 2004; 23(12):1911-27. PubMed ID: 15628748 [TBL] [Abstract][Full Text] [Related]
7. Bactericidal antisense effects of peptide-PNA conjugates. Good L; Awasthi SK; Dryselius R; Larsson O; Nielsen PE Nat Biotechnol; 2001 Apr; 19(4):360-4. PubMed ID: 11283595 [TBL] [Abstract][Full Text] [Related]
8. Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles. Liu Y; Franzen S Bioconjug Chem; 2008 May; 19(5):1009-16. PubMed ID: 18393455 [TBL] [Abstract][Full Text] [Related]
9. Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain. Koppelhus U; Shiraishi T; Zachar V; Pankratova S; Nielsen PE Bioconjug Chem; 2008 Aug; 19(8):1526-34. PubMed ID: 18646838 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of phosphorothioate oligonucleotide-peptide conjugates by solid phase fragment condensation. Diala I; Osada A; Maruoka S; Imanisi T; Murao S; Ato T; Ohba H; Fujii M Bioorg Med Chem Lett; 2007 Dec; 17(23):6576-8. PubMed ID: 17942304 [TBL] [Abstract][Full Text] [Related]
11. 4-(2-aminooxyethoxy)-2-(ethylureido)quinoline-oligonucleotide conjugates: synthesis, binding interactions, and derivatization with peptides. Hamma T; Miller PS Bioconjug Chem; 2003; 14(2):320-30. PubMed ID: 12643742 [TBL] [Abstract][Full Text] [Related]
12. A concise method for the preparation of peptide and arginine-rich peptide-conjugated antisense oligonucleotide. Chen CP; Zhang LR; Peng YF; Wang XB; Wang SQ; Zhang LH Bioconjug Chem; 2003; 14(3):532-8. PubMed ID: 12757376 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiviral activity of peptide-oligonucleotide conjugates prepared by using N alpha-(bromoacetyl)peptides. Arar K; Aubertin AM; Roche AC; Monsigny M; Mayer R Bioconjug Chem; 1995; 6(5):573-7. PubMed ID: 8974456 [TBL] [Abstract][Full Text] [Related]